Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


European Statistical Forum 2014

17 Nov 2014 - 17 Nov 2014 - Brussels, Belgium



Bookmark and Share


The EUROPEAN STATISTICAL FORUM is pleased to announce its 5th Annual Conference:

The current status of the application of Bayesian Methods in Drug Development

In the last years the biostatistics community has increased its interest in the application of Bayesian methodology in drug development as it provides a framework for determining probabilities relevant to inferences from current trials and previous knowledge.

Bayesian statistics has the potential to play an important role throughout the drug/device development process lifecycle and in particular in the decision-making process. Its range of applications contains early phase studies, dose-finding, safety analyses, meta-analyses, decision theory as well as the quantification of the benefits and risks essential to health economic evaluation. While the use of Bayesian methodologies has significantly increased in the recent years in exploratory clinical trials, its use in confirmatory clinical trials is still not common.

The fifth edition of the European Statistical Forum is dedicated to Bayesian Statistics, in particular by presenting:

  •  Current state-of-art implementation in clinical trials
  •  Recent enhancements in the methodology
  •  Regulatory perspectives on its application in clinical trials.

The conference aims at promoting the exchange of expertise in the field coming from academia and industry as well as regulators.

The Scientific Board:

  • Jens-Otto Andreas, Director, Head Global Biostatistics EU Group, UCB BIOSCIENCES GmbH
  • Lisa Comarella, Director, Biostatistics, Senior Project Manager, Cros NT Group
  • Frank Fleischer, Global BCA, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Giacomo Mordenti, Senior Director Compound Development & Branding-Head Biostatistics, Grünenthal 

will share best practices, results and experiences in this field.

Who should attend?

The conference is addressed to Statisticians and Professionals with a deep interest in the application of Bayesian methodology in clinical trials belonging to: Pharmaceutical, Biotechnology and related Industries, CROs, Academy, Hospital Centres, University.

Pre-Conference Dinner at Aux Armes de Bruxelles, Brussels

Sunday, 16th November, 7:30 pm

For further information, please visit: www.esforum.eu




Further information
Scientific News
Rates of Nonmedical Prescription Opioid Use Disorder Double in 10 Years
Researchers at NIH have found that the nonmedical use of prescription opioids has more than doubled among adults in the United States from 2001-2002 to 2012-2013.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
‘Human-on-a-Chip’ Could Replace Animal Testing
Researchers are developing a “human-on-a-chip,” a miniature external replication of the human body, integrating biology and engineering with a combination of microfluidics and multi-electrode arrays.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
‘Missing Tooth’ Hydrogels Handle Hard-to-Deliver Drugs
Rice University’s custom hydrogel traps water-avoiding molecules for slow delivery.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
Better Animal Model to Improve HIV Vaccine Development
Penn study identifies a new tool to produce better HIV vaccine designs.
Identifying Side-Effects At Early Stages Of Drug Development
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!